Perfil
Michael M.
Derkacz currently works at Braeburn, Inc., as President, Chief Executive Officer & Director from 2017.
Mr. Derkacz also formerly worked at Cephalon, Inc., as Vice President, Teva Pharmaceutical Industries Ltd., as Vice President & General Manager-CNS from 2011 to 2015, and Auspex Pharmaceuticals, Inc., as Senior Vice President.
Mr. Derkacz received his undergraduate degree in 1991 from The University of Texas at Austin.
Cargos activos de Michael M. Derkacz
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAEBURN INC. | Director Ejecutivo | 05/06/2017 |
Antiguos cargos conocidos de Michael M. Derkacz.
| Empresas | Cargo | Fin |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Formación de Michael M. Derkacz.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
- Bolsa de valores
- Insiders
- Michael M. Derkacz
















